Condition: Obesity · Overweight · Sponsor: Kailera
The primary objective of this study is to determine the efficacy of oral KAI-7535 once daily compared with placebo on percent change in body weight in participants living with obesity or overweight, with at least 1 weight-related comorbidity, without diabetes mellitus. Efficacy in participants with type 2 diabetes mellitus will be evaluated. Safety and tolerability and other weight-related outcomes will be evaluated in both types of participants.
This description comes directly from the study's public registry record.
Kailera Therapeutics, Inc. · 1-781-317-0291 · info-clinicalstudies@kailera.com
Always discuss trial participation with your own doctor first.
| Kailera Clinical Site | Chandler, Arizona, United States | Recruiting |
| Kailera Clinical Site | Phoenix, Arizona, United States | Recruiting |
| Kailera Clinical Site | Irvine, California, United States | Recruiting |
| Kailera Clinical Site | Lincoln, California, United States | Recruiting |
| Kailera Clinical Site | Northridge, California, United States | Recruiting |
| Kailera Clinical Site | Hamden, Connecticut, United States | Recruiting |
| Kailera Clinical Site | Jacksonville, Florida, United States | Recruiting |
| Kailera Clinical Site | Jupiter, Florida, United States | Recruiting |
| Kailera Clinical Site | Palm Springs, Florida, United States | Recruiting |
| Kailera Clinical Site | Pembroke Pines, Florida, United States | Recruiting |
| Kailera Clinical Site | Decatur, Georgia, United States | Recruiting |
| Kailera Clinical Site | Chicago, Illinois, United States | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07497880